BUSINESS

Takeda to Nominate CEO-Elect Kim to Board at June AGM

March 27, 2026

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

Takeda Pharmaceutical said on March 26 that its board has decided to nominate CEO-elect Julie Kim as a new director candidate at its annual general shareholders meeting scheduled for June 24, as part of its planned leadership transition. If approved…

To read the full story

Takeda Turns the Page to Kim’s “10-Year” Era, Betting on New Drugs and AI
June 26, 2026
Takeda Hands CEO Baton to Kim after 12-Year Weber Era
June 24, 2026
Julie Kim Tapped to Take Over Helm of Takeda in 2026
January 31, 2025

BUSINESS

Astellas Confirms Applying to US MFN Medicaid Pricing Model
July 7, 2026
Otsuka’s Astex Inks Breast Cancer R&D Pact with Genentech
July 7, 2026
Ribomic, Fujifilm to Join Forces on LNP CDMO Services
July 7, 2026
Toray Unveils Next-Generation Opioid Painkiller Candidate
July 7, 2026
Keytruda’s No. 1 Streak Reaches 33 Months: Encise
July 7, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Romiplate to See Steepest Cut in April Market Expansion Re-Pricing

Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…

COMMENTARY

DORA Use Could Expand as Japan Opens Door to “Sleep Disorders” Specialty

By Shinya Sato

Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…

COLUMN

The Psychology of ‘Stuck’: Understanding Why Changing Jobs Feels So Hard

By Philip Carrigan

Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…